(Q30307009)

16 June 2017

title

Gender ratio differences between Parkinson's disease patients and their affected relatives (English)

1 reference

16 June 2017

1 reference

R H. Swerdlow

1

1 reference

16 June 2017

W D. Parker

2

1 reference

16 June 2017

L J. Currie

3

1 reference

16 June 2017

J P. Bennett

4

1 reference

16 June 2017

M B. Harrison

5

1 reference

16 June 2017

J M. Trugman

6

1 reference

16 June 2017

G F. Wooten

7

1 reference

16 June 2017

publication date

1 April 2001

1 reference

16 June 2017

number of pages

5

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

16 June 2017

volume

7

1 reference

16 June 2017

issue

2

1 reference

16 June 2017

page(s)

129-133

1 reference

A clinical and genetic study of familial Parkinson's disease

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

A clinical genetic study of Parkinson's disease: evidence for dominant transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Mitochondrial DNA and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Origin and functional consequences of the complex I defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Point mutations of mitochondrial genome in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Maternal inheritance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Leber's hereditary optic neuropathy. New genetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Parkinson's disease. A genetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Parkinson's disease: a test of the multifactorial etiologic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Cerebral palsy in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Young onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

The Familial Occurrence of Parkinson's Disease Lack of Evidence for Maternal Inheritance

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Epidemiology of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

Changing epidemiology of Parkinson's disease in southwestern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900029-8

7 January 2021

10.1016/S1353-8020(00)00029-8

Identifiers

DOI

1 reference

16 June 2017

1 reference